スギ・ヒノキ花粉症におけるトシル酸スプラタスト(アイピーディ100mg)の初期治療効果の検討―患者アンケート・QOL評価よりの検討―

書誌事項

タイトル別名
  • Efficacy of the Prophylactic Suplatast Tosilate (IPD capsules 100mg) for the Treatment of Seasonal Allergies Due to Japanese Cedar and Cypress Pollen
  • ヤクブツ スギ ヒノキ カフンショウ ニ オケル トシルサン スプラタスト アイピーディ 100mg ノ ショキ チリョウ コウカ ノ ケントウ カンジャ アンケート QOL ヒョウカ ヨリ ノ ケントウ
  • 患者アンケート・QOL評価よりの検討

この論文をさがす

抄録

To assess the effects of early intervention with suplatast tosilate (IPD® capsules, 100mg), a Th2 cytokine inhibitor, in patients with allergies to Japanese cedar and cypress pollen, we studied 93 patients with this type of allergy. Symptom, medication, and symptom medication scores were lower in patients who received early intervention with suplatast tosilate than in those who received suplatast during the pollen season. The results of a survey performed with the Japanese Allergic Rhinitis Standard Quality of Life Questionnaire also indicated that the early intervention group had good outcomes. Early intervention with suplatast was thus an effective treatment for patients with allergies to cedar and Japanese cypress pollen.<br>We also surveyed the expectations of patients regarding drug treatment. We found that patients want to have drugs that exhibit a prolonged duration of action and are very effective without causing drowsiness.

収録刊行物

被引用文献 (1)*注記

もっと見る

参考文献 (18)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ